BC Week In Review | Nov 17, 2008
Clinical News

Drug-eluting GTX stent: Feasibility study started

Cook's Global Therapeutics unit began an open-label, German feasibility study to evaluate an AVI-5126-eluting GTX stent in up to 90 patients who will undergo a follow-up exam at 30 days and 6 months. The bare...
Items per page:
1 - 1 of 1